Personalized cancer vaccines are getting closer to market. Merck and Moderna just showed successful manufacturing in a large ...

Sarepta Therapeutics’ newly minted CEO Michael Severino laid out his path to returning the muscular dystrophy therapy maker ...

ADELAIDE, Australia, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Avance Clinical, a full-service biotech-focused global contract ...

CAMBRIDGE, MA / ACCESS Newswire / November 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today reported financial results and ...

Profound expects full-year 2026 revenue to be at least $25.0 million; minimum gross margin projection for the year remains at ...

Anika Therapeutics, Inc. (Nasdaq: ANIK), the global leader in the design, development, manufacturing and commercialization of ...

(NASDAQ: BCDA), a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary ...

Kristi and Kodi Share Their Experience Living with the Rare Genetic Skin Disease, Alongside Insights from Pediatric ...

Poster presentation will highlight the preclinical profile of ECC1542 and its potential for treating obesity and associated ...

Curonix, a leading medical technology company dedicated to relieving chronic pain, today announced that the Freedom® ...

Expect to complete enrollment of the BCG-Unresponsive registrational cohort of the ADVANCED-2 trial of TARA-002 in NMIBC by ...

(Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected ...